• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Auxergen, Inc.

Monday, June 03, 2024
CP
Food and Agriculture
Auxergen is a Qualified Maryland Biotech Company designated by the State of Maryland. Auxergen applies engineered bacteriophages as biocontrol reagents for plant diseases and for human and environmental health. (1) We have independently published three virology papers related to plant pathogens (bamboo mosaic virus, citrus canker, rice blight). (2) We have two patents (one issued, one pending) of our phage-based technology against plant Xylella (olive quick decline syndrome) and Xanthomonas diseases. (3) We have developed and licensed cell-based assays to analyze pharmacokinetics of cannabinoid compounds. (4) Since early 2020, we published five research articles of SARS-CoV-2 virus etiology, epidemiology, and evolution in cases. We are the first group to identify RNA recombination of SARS-CoV-2 and investigating COVID-19 viral evolution in a close environment. (5) In December 2023 and January 2024 we presented 3 new papers on filamentous phages.
Auxergen, Inc.
Company Website: http://https//auxergen.com
Lead Product in Development: XylePhage, a biologic cure for Xylella fastidiosa, a bacterial blight threatening 75% of the world's olive production.
Number Of Unlicensed Products (For Which You Are Seeking Partners): 8

Company HQ City

Baltimore

Company HQ State

Maryland

Company HQ Country

United States

CEO/Top Company Official

Gregory P Contreras

Development Phase of Primary Product

Other/Not Applicable
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS